The most important financial indicators for the company Amy Pharma Distribution Srl - Unique Identification Number 33761326:
sales in 2023 was
669.406
euro, registering a net profit of
2.231
euro and having an average number of
5
employees.
Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate.
In the last year of activity, the sales increased by 154.0%, from 264.359 euro in the year 2022, to 669.406 euro in 2023.
The Net Profit decreased by -13.831 euro, from 16.111 euro in 2022, to 2.231 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Amy Pharma Distribution Srl - CUI 33761326
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
0
0
0
0
0
0
0
0
1.186.728
Current Assets
-
75.130
44.148
200.835
200.679
253.181
384.674
367.041
712.976
533.312
Inventories
-
712
17.651
44.208
71.715
69.730
241.984
302.950
354.145
440.660
Receivables
-
74.268
24.608
149.935
116.860
172.630
108.552
49.051
25.218
49.683
Cash
-
151
1.889
6.693
12.105
10.821
34.138
14.999
128.888
42.925
Shareholders Funds
-
3.592
-11.026
10.411
40.681
107.771
274.197
311.105
328.181
329.416
Social Capital
-
337
334
328
322
316
310
303
304
303
Debts
-
71.538
55.174
190.424
159.998
145.410
110.477
55.936
384.795
1.390.624
Income in Advance
-
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
533.312 euro in 2023 which includes Inventories of
440.660 euro, Receivables of
49.683 euro and cash availability of
42.925 euro.
The company's Equity was valued at
329.416 euro, while total Liabilities amounted to
1.390.624 euro.
Equity increased by 2.230 euro, from 328.181 euro in 2022, to 329.416 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Amy Pharma Distribution Srl